Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 24;327(20):2015-2018.
doi: 10.1001/jama.2022.4877.

Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021

Marie C Bradley  1 , Silvia Perez-Vilar  1 , Yoganand Chillarige  2 , Diane Dong  3 , Ashley I Martinez  4 , Andrew R Weckstein  5 , Gerald J Dal Pan  1
Affiliations

Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021

Marie C Bradley et al. JAMA. .

Abstract

This study uses 2 large US health care claims databases (Medicare fee-for-service and the US Food and Drug Administration’s Sentinel System) to examine systemic corticosteroid use among nonhospitalized patients with COVID-19.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Mr Chillarige reported receiving personal fees from Acumen LLC. Mr Weckstein reported being employed by and having an ownership interest (stock options or existing equity) in Aetion, a technology company that provides analytic software and services to the health care industry. No other disclosures were reported.

Figures

Figure.
Figure.. Proportion of Patients With COVID-19 Initiating Systemic Corticosteroids Within 14 Days of Diagnosis
FDA indicates Food and Drug Administration; NIH, National Institutes of Health; RECOVERY, Randomised Evaluation of COVID-19 Therapy. aThe name of the corticosteroid was only available for pharmacy dispensings.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. National Institutes of Health . Therapeutic management of nonhospitalized adults with COVID-19. Updated February 1, 2022. Accessed March 30, 2022. https://www.covid19treatmentguidelines.nih.gov/management/clinical-manag...
    1. RECOVERY: Randomised Evaluation of COVID-19 Therapy . Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. Accessed February 18, 2022. https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-...
    1. Centers for Medicare & Medicaid Services . Medicare program: general information. Accessed March 3, 2021. https://www.cms.gov/Medicare/Medicare-General-Information/MedicareGenInf...
    1. Cocoros NM, Fuller CC, Adimadhyam S, et al. . A COVID-19–ready public health surveillance system. Pharmacoepidemiol Drug Saf. 2021;30(7):827-837. - PMC - PubMed
    1. Horby P, Lim WS, Emberson JR, et al. . Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693-704. - PMC - PubMed

Substances